Paediatric Neuropsychiatric Disorders Treatment Market
Market Insights on Paediatric Neuropsychiatric Disorders Treatment covering sales outlook, demand forecast & up-to-date key trends
Paediatric Neuropsychiatric Disorders Treatment Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment; 2017 - 2027
Paediatric Neuropsychiatric Disorders Treatment Market Overview
Neuropsychiatry is concerned with study of mental disorders of nervous system that arises from overt function of cerebral system. Paediatric neuropsychiatry is a clinical discipline pertaining to the study of diagnosis and treatment of behavioural and psychiatric disorders in infants, children and adolescents.
There are several factors which are hampering the functions of nervous system and cerebral function that lead to paediatric neuropsychiatric diseases. Paediatric neuropsychiatric disorders mainly caused due to chromosome disorders, congenital abnormalities, prenatal exposure to infections or toxins and trauma.
Neuropsychiatric disorders might affect the intellect, motor movement, psychological, and social functions in the paediatric patients. Children with neuropsychiatric diseases have multiple conditions with varied severity. Intellectual disability and impaired mobility are common manifestations of neuropsychiatric conditions.
Paediatric Neuropsychiatric Disorders Treatment Market: Drivers and Restraints
Global paediatric neuropsychiatric disorders treatment market is continue to witness positive growth owing to its increasing life expectancy, availability of wider off label treatment options for neuropsychiatric disorders and increasing prevalence of several paediatric neuropsychiatric disorders in recent times would expected to fuel demand paediatric neuropsychiatric disorders treatment over a period of forecast.
For instance, life time prevalence of Obsessive Compulsive Disorder (OCD) is 1-3% in general population. The market for paediatric neuropsychiatric disorders treatment driven by increasing societal stress in children, change in lifestyle and genetic abnormalities among children expected to fuel the market for paediatric neuropsychiatric disorders treatment over a period of forecast.
However, paucity of FDA approved products and lack of clinical trial Information on use of psychiatric treatment in children may hamper the growth of the paediatric neuropsychiatric disorders treatment market over a period of forecast.
Paediatric Neuropsychiatric Disorders Treatment Market: Overview
Global pediatric neuropsychiatric disorders treatment market is highly competitive with several local and multinational players operating in the market. Marketers in the pediatric neuropsychiatric disorders treatment market is working on creating diseases awareness among key stakeholders and coming up with newer formulations to improve the treatment compliance.
Among treatment types, drug treatment sub segment expected to grow at significant CAGR over the forecast period.
Paediatric Neuropsychiatric Disorders Treatment Market: Region-wise Outlook
Geographically, paediatric neuropsychiatric disorders treatment market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe expected to be key markets for paediatric neuropsychiatric disorders treatment market.
Developed markets like North America and Europe is expected to witness robust growth owing to increased awareness, advanced healthcare infrastructure, reimbursement policies in the region. Asia Pacific region is anticipated to register positive growth owing to favourable patient demographics and rising neuropsychiatric disorders prevalence in the region.
Paediatric Neuropsychiatric Disorders Treatment Market: Key Players
Some players in paediatric neuropsychiatric disorders Treatment market include Boehringer Ingelheim GmbH, Biogen, Eli Lilly and Company, Pfizer Inc., Otsuka Holdings Co. Ltd, to name a few.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report covers exhaustive analysis on
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil and Rest of Latin America)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
- Eastern Europe (Poland, Russia and Rest of Eastern Europe)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC, S. Africa, and Rest of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Paediatric Neuropsychiatric Disorders Treatment Market: Segmentation
Global pediatric neuropsychiatric disorders treatment market has been segmented on the basis of disorder type, treatment type, end user and region
Based on the disorder type, the global pediatric neuropsychiatric disorders treatment market is segmented into the following:
- Asperger’s Syndrome
- Cerebral Palsy
- Obsessive Compulsive Disorder (OCD)
- Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)
- Autoimmune Neuropsychiatric Disorder
Based on the treatment type, the global pediatric neuropsychiatric disorders treatment market is segmented into the following:
- Drug Treatment
- Electric Treatment
- Magnetic Treatment
Based on the end user, the global pediatric neuropsychiatric disorders treatment market is segmented into the following:
- Ambulatory Surgical centers
- Rehabilitation Centers